This rare condition can lead to: low plasma carnitine progressive cardiomyopathy, or heart muscle disease skeletal myopathy hypoglycemia hypoammonemia weak muscles in the hips, shoulders upper arms, legs, neck, and jaw muscles Untreated it is fatal
High-quality human clinical trials are lacking, and optimal dosing, long-term safety, and efficacy have not been established, meaning its use for IBS and Crohns should be considered investigational rather than a standard therapeutic option
Microbial short-chain fatty acids modulate CD8 + T cell responses and improve adoptive immunotherapy for cancer
It is an experimental compound studied extensively in preclinical (animal) models for its potential regenerative and cytoprotective properties, particularly in healing soft tissues, reducing inflammation, and protecting organs